(3R)-N-[3-[5-(2-Cyclopropylpyrimidin-5-Yl)-1H-Pyrrolo[2,3-B]Pyridine-3-Carbonyl]-2,4-Difluorophenyl]-3-Fluoropyrrolidine-1-Sulfonamide

1 trials 1 recruiting

Filter these 1 trials by condition, phase, country and more.

Open in Search →
1 Registered trials
1 Recruiting
0 Completed trials
1 Sponsors
7 Countries
Phase II: 1

Indications tested

BRAF gene mutation 1 BRAF V600E mutation positive 1

Sponsors using this IMP

Iovance Biotherapeutics Inc. 1

All trials

1 total

Showing 1–1 of 1 trials

← All drugs A–Z